Spectrum Pharmaceuticals Inc. (SPPI) Fundamentals

Spectrum Pharmaceuticals Inc operates in the healthcare sector in the United States. It is a biopharmaceutical company with a primary strategy comprised of acquiring, developing and commercializing novel and targeted oncology therapies. Eflapegrastim and Poziotinib are it's current drugs in last stage development. Eflapegrastim is a novel long-acting granulocyte colony-stimulating factor ("G-CSF") for the treatment of chemotherapy-induced neutropenia and Poziotinib is a novel irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer ("NSCLC") tumors with various mutations.
SHARE INFORMATION
Market Cap$ 217,905,535
Shares Outstanding180,087,219
Float178,554,156
Percent Float99.15%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.02
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment CashCash
HOLDERS
Institutions307
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months16,158,243
Institutional Holdings Percent59.1%
Institutional Sold Previous 3 Months78,519,632
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months7,867,086
Insider Holdings Percent2.9
Insider Sold Previous 3 Months30,609
Insider Shares Owned5,293,978
TRADING INFO
52 Week High$ 2.53
52 Week Low$ 0.60
52 Week High Change$ -48.51
21 Day Moving Average$ 0.907
21 Day Extended Moving Average$ 0.945823
50 Day Moving Average$ 0.8567
50 Day Extended Moving Average$ 0.890647
200 Day Moving Average$ 1.0886
200 Day Extended Moving Average$ 1.2419
10 Day Average Volume2,373,414
20 Day Average Volume1,712,964
30 Day Average Volume1,595,759
50 Day Average Volume2,228,021
Alpha-0.026458
Beta2.0023
Standard Deviation0.243944
R20.168537
7 Day Price Change$ 0.2743
7 Day Percent Change29.32%
21 Day Price Change$ 0.35
21 Day Percent Change40.7%
30 Day Price Change$ 0.39
30 Day Percent Change47.56%
Month to Date Price Change$ 0.397
Month to Date Percent Change48.83%
Quarter to Date Price Change$ 0.43
Quarter to Date Percent Change55.13%
180 Day Price Change$ 0.4965
180 Day Percent Change69.59%
200 Day Price Change$ 0.26
200 Day Percent Change27.37%
Year to Date Price Change$ -0.06
Year to Date Percent Change-4.72%

Spectrum Pharmaceuticals Inc. (SPPI) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.70
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio2.40
Leverage Ratio2.10
Quick Ratio2.30
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.30
Enterprise Value$ 113,484,685
Price to Sales0.00
Price to Free Cash-2.40
PE High Last 5 Years-3.50
Price To Book3.70
Price To Cash Flow90.30
PE Low Last 5 Years-5.70
Price to Tangible Book3.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-102.85
Return on Equity-161.96
Return on Capital-153.71

Spectrum Pharmaceuticals Inc. (SPPI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorRSM US LLP
CEOThomas J. Riga
Emplyoees164
Last AuditUQ
CIK0000831547
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address11500 South Eastern Avenue
Suite 220
Henderson, NV 89052
Websitehttps://www.sppirx.com
Facsimile+1 702 260-7405
Telephone+1 702 835-6300
EmailInvestorRelations@sppirx.com
Your Recent History
NASDAQ
SPPI
Spectrum P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20220813 17:41:32